Erste Group analyst Hans Engel downgraded Pfizer to Hold from Buy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Acepodia enters strategic clinical collaboration with Pfizer
- H.C. Wainwright positive on second booster results for VLA15
- Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
- iRhythm Technologies announces results of GUARD-AF trial
- Statement from President Biden on anti-obesity medications pricing